Development of a recombinase polymerase amplification lateral flow assay for the detection of active Trypanosoma evansi infections.
Journal
PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488
Informations de publication
Date de publication:
02 2020
02 2020
Historique:
received:
13
08
2019
accepted:
09
01
2020
revised:
28
02
2020
pubmed:
19
2
2020
medline:
28
4
2020
entrez:
19
2
2020
Statut:
epublish
Résumé
Animal trypanosomosis caused by Trypanosoma evansi is known as "surra" and is a widespread neglected tropical disease affecting wild and domestic animals mainly in South America, the Middle East, North Africa and Asia. An essential necessity for T. evansi infection control is the availability of reliable and sensitive diagnostic tools. While DNA-based PCR detection techniques meet these criteria, most of them require well-trained and experienced users as well as a laboratory environment allowing correct protocol execution. As an alternative, we developed a recombinase polymerase amplification (RPA) test for Type A T. evansi. The technology uses an isothermal nucleic acid amplification approach that is simple, fast, cost-effective and is suitable for use in minimally equipped laboratories and even field settings. An RPA assay targeting the T. evansi RoTat1.2 VSG gene was designed for the DNA-based detection of T. evansi. Comparing post-amplification visualization by agarose gel electrophoresis and a lateral flow (LF) format reveals that the latter displays a higher sensitivity. The RPA-LF assay is specific for RoTat1.2-expressing strains of T. evansi as it does not detect the genomic DNA of other trypanosomatids. Finally, experimental mouse infection trials demonstrate that the T. evansi specific RPA-LF can be employed as a test-of-cure tool. Compared to other DNA-based parasite detection methods (such as PCR and LAMP), the T. evansi RPA-LF (TevRPA-LF) described in this paper is an interesting alternative because of its simple read-out (user-friendly), short execution time (15 minutes), experimental sensitivity of 100 fg purified genomic T. evansi DNA, and ability to be carried out at a moderate, constant temperature (39°C). Therefore, the TevRPA-LF is an interesting tool for the detection of active T. evansi infections.
Sections du résumé
BACKGROUND
Animal trypanosomosis caused by Trypanosoma evansi is known as "surra" and is a widespread neglected tropical disease affecting wild and domestic animals mainly in South America, the Middle East, North Africa and Asia. An essential necessity for T. evansi infection control is the availability of reliable and sensitive diagnostic tools. While DNA-based PCR detection techniques meet these criteria, most of them require well-trained and experienced users as well as a laboratory environment allowing correct protocol execution. As an alternative, we developed a recombinase polymerase amplification (RPA) test for Type A T. evansi. The technology uses an isothermal nucleic acid amplification approach that is simple, fast, cost-effective and is suitable for use in minimally equipped laboratories and even field settings.
METHODOLOGY/PRINCIPLE FINDINGS
An RPA assay targeting the T. evansi RoTat1.2 VSG gene was designed for the DNA-based detection of T. evansi. Comparing post-amplification visualization by agarose gel electrophoresis and a lateral flow (LF) format reveals that the latter displays a higher sensitivity. The RPA-LF assay is specific for RoTat1.2-expressing strains of T. evansi as it does not detect the genomic DNA of other trypanosomatids. Finally, experimental mouse infection trials demonstrate that the T. evansi specific RPA-LF can be employed as a test-of-cure tool.
CONCLUSIONS/SIGNIFICANCE
Compared to other DNA-based parasite detection methods (such as PCR and LAMP), the T. evansi RPA-LF (TevRPA-LF) described in this paper is an interesting alternative because of its simple read-out (user-friendly), short execution time (15 minutes), experimental sensitivity of 100 fg purified genomic T. evansi DNA, and ability to be carried out at a moderate, constant temperature (39°C). Therefore, the TevRPA-LF is an interesting tool for the detection of active T. evansi infections.
Identifiants
pubmed: 32069278
doi: 10.1371/journal.pntd.0008044
pii: PNTD-D-19-01398
pmc: PMC7048301
doi:
Substances chimiques
DNA, Protozoan
0
Recombinases
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0008044Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Parasitol Res. 2011 Sep;109(3):559-65
pubmed: 21350794
Rev Elev Med Vet Pays Trop. 1993;46(3):455-61
pubmed: 8190982
Anal Chem. 2016 Feb 2;88(3):1610-6
pubmed: 26669715
Vet Parasitol. 2013 Mar 31;193(1-3):47-58
pubmed: 23305969
Biosens Bioelectron. 2014 Apr 15;54:674-8
pubmed: 24334283
Clin Chem. 2016 Jul;62(7):947-58
pubmed: 27160000
Wkly Epidemiol Rec. 2005 Feb 18;80(7):62-3
pubmed: 15771199
PLoS One. 2015 Jun 15;10(6):e0129682
pubmed: 26075598
Vet Parasitol. 2005 Jun 10;130(1-2):163-8
pubmed: 15893083
Trop Anim Health Prod. 2010 Feb;42(2):145-50
pubmed: 19642008
Int J Parasitol. 1992 Nov;22(7):909-18
pubmed: 1459784
Euro Surveill. 2015;20(44):
pubmed: 26558690
Mol Biochem Parasitol. 1987 Feb;23(1):31-8
pubmed: 3033499
Parasit Vectors. 2015 Apr 09;8:212
pubmed: 25889702
Exp Parasitol. 2005 May;110(1):30-8
pubmed: 15804376
Vet Parasitol. 2018 Jan 30;250:1-6
pubmed: 29329617
Infect Genet Evol. 2007 Mar;7(2):305-7
pubmed: 16934537
Foodborne Pathog Dis. 2014 Jul;11(7):529-36
pubmed: 24749488
Int J Environ Res Public Health. 2014 May 08;11(5):4953-64
pubmed: 24814943
Am J Trop Med Hyg. 2015 Nov;93(5):970-5
pubmed: 26240156
Parasit Vectors. 2011 Mar 04;4:31
pubmed: 21375725
Trop Med Parasitol. 1988 Mar;39(1):45-50
pubmed: 3291076
Vet Parasitol. 2001 Jun 12;97(3):183-9
pubmed: 11390070
Comp Immunol Microbiol Infect Dis. 1998 Jul;21(3):215-23
pubmed: 9681244
Biomed Res Int. 2013;2013:194176
pubmed: 24024184
Vet Parasitol. 2011 Dec 15;182(2-4):337-42
pubmed: 21700393
PLoS One. 2017 Jan 3;12(1):e0166903
pubmed: 28045956
Expert Rev Mol Diagn. 2014 Sep;14(7):827-43
pubmed: 25052202
Exp Parasitol. 2010 Jul;125(3):196-201
pubmed: 20109454
Vet Parasitol. 1990 May;36(1-2):141-6
pubmed: 2382382
Kinetoplastid Biol Dis. 2004 Sep 17;3(1):3
pubmed: 15377385
J Dairy Sci. 2017 Sep;100(9):7016-7025
pubmed: 28711269
Acta Trop. 2004 May;90(3):271-5
pubmed: 15099814
PLoS Biol. 2006 Jul;4(7):e204
pubmed: 16756388
Ann Soc Belg Med Trop. 1988 Sep;68(3):233-40
pubmed: 3223785
J Virol Methods. 2014 Nov;208:144-51
pubmed: 25152528
Vet Parasitol. 2003 Nov 3;117(1-2):1-13
pubmed: 14597273
Mol Biochem Parasitol. 1990 May;40(2):279-83
pubmed: 2163493
Ann Trop Med Parasitol. 2005 Jun;99(4):359-70
pubmed: 15949183
Vet Parasitol. 2004 Feb 26;120(1-2):23-33
pubmed: 15019140
Am J Trop Med Hyg. 2005 Sep;73(3):491-5
pubmed: 16172469
Clin Infect Dis. 2016 Apr 15;62(8):1002-1008
pubmed: 26908809
Parasit Vectors. 2015 Aug 12;8:415
pubmed: 26259616
Trop Biomed. 2007 Dec;24(2):67-70
pubmed: 18209710
Vet Parasitol. 2010 Jan 20;167(1):74-6
pubmed: 19864069
Expert Rev Mol Diagn. 2015;15(11):1475-89
pubmed: 26517245
Infect Genet Evol. 2006 Jul;6(4):292-300
pubmed: 16157514
Trends Immunol. 2011 Feb;32(2):80-8
pubmed: 21159556
Vet Parasitol. 2008 May 31;153(3-4):255-64
pubmed: 18374490
Vet Parasitol. 1995 Nov;60(1-2):167-71
pubmed: 8644453
J Virol Methods. 2017 May;243:98-104
pubmed: 28159666
Virol J. 2015 Dec 02;12:206
pubmed: 26631157
PLoS Negl Trop Dis. 2013 Sep 12;7(9):e2256
pubmed: 24069464
Exp Parasitol. 2001 Dec;99(4):181-9
pubmed: 11888244
Vet Parasitol. 1999 Jan 28;80(4):281-7
pubmed: 9950334
Proc Natl Acad Sci U S A. 2008 Feb 12;105(6):1999-2004
pubmed: 18245376
PLoS Negl Trop Dis. 2016 Apr 01;10(4):e0004556
pubmed: 27035661
Vet Rec. 2008 Jun 7;162(23):750-2
pubmed: 18540034
Acta Trop. 2018 Jun;182:4-11
pubmed: 29452112
Exp Parasitol. 1989 Nov;69(4):317-23
pubmed: 2806458